# GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors

> **NCT03185169** · EARLY_PHASE1 · TERMINATED · sponsor: **Alta Bates Summit Medical Center** · enrollment: 14 (estimated)

## Conditions studied

- Genitourinary Abnormality
- Breast Cancer Female
- Vaginal Abnormality
- Urinary Tract Infections
- Dyspareunia
- Dysuria

## Interventions

- **COMBINATION_PRODUCT:** Replens and coconut oil

## Key facts

- **NCT ID:** NCT03185169
- **Lead sponsor:** Alta Bates Summit Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11-18
- **Primary completion:** 2018-07-23
- **Final completion:** 2018-07-23
- **Target enrollment:** 14 (ESTIMATED)
- **Why stopped:** Study design change required protocol/ICF changes, deemed more appropriate to terminate study and apply knowledge gained to potential future study design
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03185169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03185169, "GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03185169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*